Intermediate filaments (IF), a subfamily of the cytoskeletal filaments, provide structural support to cells. Human diseases related to mutations in IF proteins in which their tissue-specific expression is reflected have been found in a broad range of patients. The properties of identified IF mutants are well-studied in vitro in cultured cells and in vivo using transgenic mice expressing IF mutants. However, the association of IF proteins with diseases of the lung is not fully studied yet. Epithelial cells in normal lung express vimentin and various keratins, and the patterns of their expression are altered depending on the progression of the lung diseases. A growing number of studies performed in alveolar epithelial cells demonstrated IF involvement in disease-related aspects including their usefulness as tumor marker, in epithelial-mesenchymal transition and cell migration. However, the lung disease-associated IF functions in animal models are poorly understood, and IF mutations associated with lung diseases in humans have not been reported. In this review, we summarize recent studies that show the significance of IF proteins in lung epithelial cells. Understanding these aspects is an important prerequisite for further investigations on the role of lung IF in animal models and human lung diseases.
Keratins are the largest subfamily of intermediate filament proteins. They are either type I acidic or type II basic keratins. Keratins form obligate heteropolymer in epithelial cells and their expression patterns are tissue-specific. Studies have shown that keratin mutations are the cause of many diseases in humans or predispose humans to acquiring them. Using mouse models to study keratin-associated human diseases is critical, because they allow researchers to get a better understanding of these diseases and their progressions, and so many such studies have been conducted. Acknowledging the importance, researches with genetically modified mice expressing human disease-associated keratin mutants have been widely done. Numerous studies using keratin knockout mice, keratin-overexpressed mice, or transgenic mice expressing keratin mutants have been conducted. This review summarizes the mouse models that have been used to study type I and type II keratin expression in the digestive organs, namely, the liver, pancreas, and colon.
Keratin 8 (K8) and keratin 18 (K18) are the intermediate filament proteins whose phosphorylation/transamidation associate with their aggregation in Mallory‐Denk bodies found in patients with various liver diseases. However, the functions of other post‐translational modifications in keratins related to liver diseases have not been fully elucidated. Here, using a site‐specific mutation assay combined with nano‐liquid chromatography‐tandem mass spectrometry, we identified K8‐Lys108 and K18‐Lys187/426 as acetylation sites, and K8‐Arg47 and K18‐Arg55 as methylation sites. Keratin mutation (Arg‐to‐Lys/Ala) at the methylation sites, but not the acetylation sites, led to decreased stability of the keratin protein. We compared keratin acetylation/methylation in liver disease–associated keratin variants. The acetylation of K8 variants increased or decreased to various extents, whereas the methylation of K18‐del65‐72 and K18‐I150V variants increased. Notably, the highly acetylated/methylated K18‐I150V variant was less soluble and exhibited unusually prolonged protein stability, which suggests that additional acetylation of highly methylated keratins has a synergistic effect on prolonged stability. Therefore, the different levels of acetylation/methylation of the liver disease–associated variants regulate keratin protein stability. These findings extend our understanding of how disease–associated mutations in keratins modulate keratin acetylation and methylation, which may contribute to disease pathogenesis.—Jang, K.‐H., Yoon, H.‐N., Lee, J., Yi, H., Park, S.‐Y., Lee, S.‐Y., Lim, Y., Lee, H.‐J., Cho, J.‐W., Paik, Y.‐K., Hancock, W. S., Ku, N.‐O. Liver disease–associated keratin 8 and 18 mutations modulate keratin acetylation and methylation. FASEB J. 33, 9030–9043 (2019). http://www.fasebj.org
Keratin 8 (K8) is the cytoskeletal intermediate filament protein of simple-type epithelia. Mutations in K8 predispose the affected individual and transgenic mouse to liver disease. However, its role in lung has not been reported in mutant transgenic mouse models. Here, we investigated the susceptibility of two different transgenic mice expressing K8 gly-62-cys or ser-74-ala to lung injury. The mutant transgenic mice were highly susceptible to two independent acute and chronic lung injuries as compared with control mice. Both K8 gly-62-cys mice and K8 ser-74-ala mice showed the markedly enhanced mouse lethality (∼74% mutant mice vs. ∼34% control mice) and more severe lung damage with increased inflammation and apoptosis under L-arginine-mediated acute lung injury. Moreover, the K8 ser-74-ala mice had more severe lung damage with extensive hemorrhage and prominent fibrosis under bleomycin-induced chronic lung injury. Our study provides first direct evidence that the K8 mutations predispose to lung injury in transgenic mice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.